{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:52:45Z","timestamp":1777650765748,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>IR injury is an unavoidable consequence in deceased donor liver transplantation. Cold preservation and warm reperfusion may change the expression and function of drug transporters in the liver due to vasoconstriction, infiltration of neutrophils and release of cytokines. We hypothesize that vasodilation, anti-platelet aggregation and proinflammatory downregulation activities of treprostinil will diminish the IR injury and its associated effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Livers obtained from male SD rats (n\u2009=\u200920) were divided into 1) Control, 2) IR, 3) Treprostinil-1 (preservation only), and 4) Treprostinil-2 (preservation and reperfusion) groups. Control livers were procured and immediately reperfused. Livers in the other groups underwent preservation for 24\u00a0h and were reperfused. All the livers were perfused using an Isolated Perfused Rat Liver (IPRL) system. Periodic perfusate, cumulative bile samples and liver tissue at the end of perfusion were collected. Liver injury markers, bile flow rates, m-RNA levels for uptake and efflux transporters (qRT-PCR) were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cold preservation and warm reperfusion significantly increased the release of AST and ALT in untreated livers. Treprostinil supplementation substantially reduced liver injury. Bile flow rate was significantly improved in treprostinil-2 group. m-RNA levels of Slc10a1, Slc22a1, and Slc22a7 in liver were increased and m-RNA levels of Mdr1a were decreased by IR. Treprostinil treatment increased Abcb11 and Abcg2 m-RNA levels and maintained Slc22a1m-RNA similar to control livers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Treprostinil treatment significantly reduced liver injury. IR injury changed expression of both uptake and efflux transporters in rat livers. Treprostinil significantly altered the IR injury mediated changes in m-RNA expression of transporters.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11095-022-03384-x","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T20:02:41Z","timestamp":1662580961000},"page":"2979-2990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treprostinil Supplementation Ameliorates Hepatic Ischemia Reperfusion Injury and Regulates Expression of Hepatic Drug Transporters: An Isolated Perfused Rat Liver (IPRL) Study"],"prefix":"10.1007","volume":"39","author":[{"given":"Omar Abdulhameed","family":"Almazroo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imam H","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"3384_CR1","unstructured":"UNOS data. [cited 2021 3 Feb]; Available from: (http:\/\/optn.transplant.hrsa.gov)."},{"key":"3384_CR2","doi-asserted-by":"crossref","unstructured":"Kwong A, et al. OPTN\/SRTR 2018 annual data report: liver. Am J Transplant, 2020. 20 Suppl s1: p. 193\u2013299.","DOI":"10.1111\/ajt.15674"},{"key":"3384_CR3","doi-asserted-by":"crossref","unstructured":"Fondevila CB, RW, Kupiec-Weglinski JW. Ischemia-reperfusion injury of the liver, in transplantation of the liver, R.W. Busuttil and G.B. Klintmalm, Editors. 2005, Elsevier Saunders: Philadelphia. p. 1403\u20131414.","DOI":"10.1016\/B978-0-7216-0118-2.50092-6"},{"key":"3384_CR4","doi-asserted-by":"crossref","unstructured":"Chen Hao, XJ, Shen Baiyong, Deng Xiaxing, Tao Ran, Peng Chenghong, Li Hongwei, Initial poor graft dysfunction and primary graft non-function after orthotopic liver transplantation, in liver biopsy in modern medicine, Y Mizuguchi, Editor 2011, InTech. p. 378.","DOI":"10.5772\/19283"},{"issue":"3","key":"3384_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/10837450902891295","volume":"41","author":"MS Benedetti","year":"2009","unstructured":"Benedetti MS, et al. Drug metabolism and pharmacokinetics. Drug Metab Rev. 2009;41(3):344\u201390.","journal-title":"Drug Metab Rev"},{"issue":"4","key":"3384_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.ajkd.2014.09.015","volume":"65","author":"BK Thomson","year":"2015","unstructured":"Thomson BK, et al. Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms. Am J Kidney Dis. 2015;65(4):574\u201382.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3384_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1053\/jlts.2003.50179","volume":"9","author":"S Masuda","year":"2003","unstructured":"Masuda S, et al. Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation. Liver Transpl. 2003;9(10):1108\u201313.","journal-title":"Liver Transpl"},{"issue":"2","key":"3384_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.18433\/J3MS40","volume":"15","author":"R Parasrampuria","year":"2012","unstructured":"Parasrampuria R, Shaik IH, Mehvar R. Effects of in vivo hepatic ischemia-reperfusion injury on the hepatobiliary disposition of rhodamine 123 and its metabolites in isolated perfused rat livers. J Pharm Pharm Sci. 2012;15(2):318\u201328.","journal-title":"J Pharm Pharm Sci"},{"key":"3384_CR9","doi-asserted-by":"crossref","unstructured":"International Transporter, C., et al., Membrane transporters in drug development. Nat Rev Drug Discov, 2010. 9(3): p. 215\u2013236.","DOI":"10.1038\/nrd3028"},{"issue":"5","key":"3384_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00424-003-1192-y","volume":"447","author":"MA Hediger","year":"2004","unstructured":"Hediger MA, et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch. 2004;447(5):465\u20138.","journal-title":"Pflugers Arch"},{"issue":"5","key":"3384_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/clpt.2012.44","volume":"92","author":"KM Morrissey","year":"2012","unstructured":"Morrissey KM, et al. The UCSF-FDA TransPortal: a public drug transporter database. Clin Pharmacol Ther. 2012;92(5):545\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3384_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/clpt.2013.77","volume":"94","author":"D Tweedie","year":"2013","unstructured":"Tweedie D, et al. Transporter studies in drug development: experience to date and follow-up on decision trees from the international transporter consortium. Clin Pharmacol Ther. 2013;94(1):113\u201325.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"3384_CR13","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/j.1600-6143.2011.03568.x","volume":"11","author":"N Ghonem","year":"2011","unstructured":"Ghonem N, et al. Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation. Am J Transplant. 2011;11(11):2508\u201316.","journal-title":"Am J Transplant"},{"issue":"1","key":"3384_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1013603331899","volume":"19","author":"R Mehvar","year":"2002","unstructured":"Mehvar R, Zhang X. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-alpha production ex vivo. Pharm Res. 2002;19(1):47\u201353.","journal-title":"Pharm Res"},{"issue":"7","key":"3384_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1023\/A:1024402121053","volume":"20","author":"AP Chimalakonda","year":"2003","unstructured":"Chimalakonda AP, Mehvar R. Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug. Pharm Res. 2003;20(7):1001\u20138.","journal-title":"Pharm Res"},{"issue":"12","key":"3384_CR16","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1002\/jps.22708","volume":"100","author":"IH Shaik","year":"2011","unstructured":"Shaik IH, Mehvar R. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats. J Pharm Sci. 2011;100(12):5281\u201392.","journal-title":"J Pharm Sci"},{"key":"3384_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-7-3","volume":"7","author":"A Schroeder","year":"2006","unstructured":"Schroeder A, et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006;7:3.","journal-title":"BMC Mol Biol"},{"key":"3384_CR18","unstructured":"Mueller OL, S, Schroeder A. RNA integrity number (RIN) standardization of RNA quality control. Agilent Technologies, 2016: p. 8."},{"issue":"4","key":"3384_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"3384_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1517\/17425255.2016.1139574","volume":"12","author":"Y Guo","year":"2016","unstructured":"Guo Y, et al. Regulation of drug-metabolizing enzymes by local and systemic liver injuries. Expert Opin Drug Metab Toxicol. 2016;12(3):245\u201351.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"3384_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/archsurg.1994.01420250051006","volume":"129","author":"A Sauaia","year":"1994","unstructured":"Sauaia A, et al. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129(1):39\u201345.","journal-title":"Arch Surg"},{"issue":"6","key":"3384_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/lt.22243","volume":"17","author":"M Verweij","year":"2011","unstructured":"Verweij M, et al. Preoperative fasting protects mice against hepatic ischemia\/reperfusion injury: mechanisms and effects on liver regeneration. Liver Transpl. 2011;17(6):695\u2013704.","journal-title":"Liver Transpl"},{"issue":"2","key":"3384_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jss.2008.09.016","volume":"159","author":"IH Shaik","year":"2010","unstructured":"Shaik IH, Mehvar R. Effects of cytochrome p450 inhibition by cimetidine on the warm hepatic ischemia-reperfusion injury in rats. J Surg Res. 2010;159(2):680\u20138.","journal-title":"J Surg Res"},{"issue":"2","key":"3384_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.1840160226","volume":"16","author":"T Ikeda","year":"1992","unstructured":"Ikeda T, et al. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology. 1992;16(2):454\u201361.","journal-title":"Hepatology"},{"issue":"6","key":"3384_CR25","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1023\/B:PHAM.0000029290.54167.7c","volume":"21","author":"AP Chimalakonda","year":"2004","unstructured":"Chimalakonda AP, Mehvar R. Effects of duration of ischemia and donor pretreatment with methylprednisolone or its macromolecular prodrug on the disposition of indocyanine green in cold-preserved rat livers. Pharm Res. 2004;21(6):1000\u20138.","journal-title":"Pharm Res"},{"issue":"1","key":"3384_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.18433\/J33C7B","volume":"17","author":"CA Thorling","year":"2014","unstructured":"Thorling CA, et al. Effects of long-term hepatic ischemia-reperfusion injury on the function of P-glycoprotein in vivo in rats. J Pharm Pharm Sci. 2014;17(1):121\u201335.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"3384_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.vascn.2012.10.001","volume":"67","author":"A Ferrigno","year":"2013","unstructured":"Ferrigno A, Richelmi P, Vairetti M. Troubleshooting and improving the mouse and rat isolated perfused liver preparation. J Pharmacol Toxicol Methods. 2013;67(2):107\u201314.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"3","key":"3384_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1258\/002367706777611460","volume":"40","author":"M Bessems","year":"2006","unstructured":"Bessems M, et al. The isolated perfused rat liver: standardization of a time-honoured model. Lab Anim. 2006;40(3):236\u201346.","journal-title":"Lab Anim"},{"issue":"3","key":"3384_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00007890-198909000-00020","volume":"48","author":"PD Greig","year":"1989","unstructured":"Greig PD, et al. Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation. 1989;48(3):447\u201353.","journal-title":"Transplantation"},{"issue":"12","key":"3384_CR30","first-page":"1079","volume":"111","author":"H Liu","year":"1998","unstructured":"Liu H, et al. Experimental study on liver microcirculation disturbance following transplantation and the protective effect of prostaglandin E1 in the rat. Chin Med J. 1998;111(12):1079\u201382.","journal-title":"Chin Med J"},{"issue":"5","key":"3384_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00007890-200009150-00004","volume":"70","author":"R Valero","year":"2000","unstructured":"Valero R, et al. L-arginine reduces liver and biliary tract damage after liver transplantation from non-heart-beating donor pigs. Transplantation. 2000;70(5):730\u20137.","journal-title":"Transplantation"},{"issue":"1","key":"3384_CR32","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1152\/ajpgi.00175.2006","volume":"293","author":"L Fouassier","year":"2007","unstructured":"Fouassier L, et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol. 2007;293(1):G25\u201335.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"3384_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0030-1253225","volume":"30","author":"M Wagner","year":"2010","unstructured":"Wagner M, Zollner G, Trauner M. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin Liver Dis. 2010;30(2):160\u201377.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"3384_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/01.tp.0000226243.69023.54","volume":"82","author":"Y Tanaka","year":"2006","unstructured":"Tanaka Y, et al. Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. Transplantation. 2006;82(2):258\u201366.","journal-title":"Transplantation"},{"issue":"2","key":"3384_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/TP.0b013e3181e0deaf","volume":"90","author":"L Cheng","year":"2010","unstructured":"Cheng L, et al. Role of cholangiocyte bile acid transporters in large bile duct injury after rat liver transplantation. Transplantation. 2010;90(2):127\u201334.","journal-title":"Transplantation"},{"issue":"1","key":"3384_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/clinids\/7.1.1","volume":"7","author":"TR Franson","year":"1985","unstructured":"Franson TR, Hierholzer WJ Jr, LaBrecque DR. Frequency and characteristics of hyperbilirubinemia associated with bacteremia. Rev Infect Dis. 1985;7(1):1\u20139.","journal-title":"Rev Infect Dis"},{"issue":"2","key":"3384_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00024382-200014020-00017","volume":"14","author":"PK Kim","year":"2000","unstructured":"Kim PK, et al. Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock. 2000;14(2):176\u201381.","journal-title":"Shock"},{"issue":"3","key":"3384_CR38","first-page":"359","volume":"7","author":"C Fernandez","year":"2004","unstructured":"Fernandez C, et al. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharm Sci. 2004;7(3):359\u201371.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"3384_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0162-3109(00)00271-X","volume":"1","author":"G Hartmann","year":"2001","unstructured":"Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1(2):189\u201399.","journal-title":"Int Immunopharmacol"},{"issue":"48","key":"3384_CR40","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.3748\/wjg.v18.i48.7194","volume":"18","author":"XH Zhu","year":"2012","unstructured":"Zhu XH, et al. Establishment of a rat liver transplantation model with prolonged biliary warm ischemia time. World J Gastroenterol. 2012;18(48):7194\u2013200.","journal-title":"World J Gastroenterol"},{"key":"3384_CR41","doi-asserted-by":"crossref","unstructured":"Cavalcanti AB\u00a0et al. Prostaglandins for adult liver transplanted patients. Cochrane Database Syst Rev, 2011(11): p. CD006006.","DOI":"10.1002\/14651858.CD006006.pub2"},{"issue":"1","key":"3384_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0163-7258(93)90067-N","volume":"58","author":"J Quiroga","year":"1993","unstructured":"Quiroga J, Prieto J. Liver cytoprotection by prostaglandins. Pharmacol Ther. 1993;58(1):67\u201391.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"3384_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00007890-199510150-00008","volume":"60","author":"JC Garcia-Valdecasas","year":"1995","unstructured":"Garcia-Valdecasas JC, et al. Prostacyclin, thromboxane, and oxygen free radicals and postoperative liver function in human liver transplantation. Transplantation. 1995;60(7):662\u20137.","journal-title":"Transplantation"},{"issue":"1\u20132","key":"3384_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prostaglandins.2006.12.004","volume":"83","author":"EM Zardi","year":"2007","unstructured":"Zardi EM, et al. Prostacyclin in sepsis: a systematic review. Prostaglandins Other Lipid Mediat. 2007;83(1\u20132):1\u201324.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"3384_CR45","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/jlb.55.5.662","volume":"55","author":"DN Granger","year":"1994","unstructured":"Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994;55(5):662\u201375.","journal-title":"J Leukoc Biol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:18:19Z","timestamp":1667492299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3384"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03384-x","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was partially funded by a grant from United Therapeutics Corporation and United Therapeutics Corporation provided Treprostinil (intervention drug).Almazroo OA currently works at Saudi Food and Drug Authority, Riyadh, Saudi Arabia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}